Welcome to our dedicated page for Mustgrow Biologics news (Ticker: MGROF), a resource for investors and traders seeking the latest updates and insights on Mustgrow Biologics stock.
MustGrow Biologics Corp (MGROF) pioneers sustainable agriculture through mustard plant-derived biofertility and biocontrol solutions. This page serves as the definitive source for official company announcements and third-party analysis.
Access real-time updates on regulatory milestones, product innovations like TerraSante™, and strategic partnerships with industry leaders. Investors will find earnings reports, commercialization progress, and market expansion news critical for informed decision-making.
Our curated feed includes press releases about organic certifications, agricultural trials, and distribution agreements across key U.S. farming regions. Bookmark this page to track MustGrow's advancements in soil health technology and eco-friendly crop protection solutions.
MustGrow Biologics Corp. (TSXV: MGRO, OTCQB: MGROF, FSE: 0C0) announced the outcomes of its 2024 annual shareholder meeting held on June 27, 2024. Shareholders voted to elect all director nominees listed in the management information circular dated May 28, 2024. The directors elected were Corey Giasson, Colin Bletsky, Brad Munro, Thomas Flow, Matt Kowalski, David Borecky, and Laura Westby, each receiving over 99.76% of the votes in favor.
Additionally, shareholders reappointed Ernst & Young LLP as the auditors and authorized the directors to determine their remuneration. The shareholders also reapproved the company's omnibus equity incentive plan, which is still subject to final TSX Venture Exchange approval. Detailed voting results will be available on SEDAR+.
MustGrow has received California registration and organic approval for its TerraSanteTM biofertility product. The approval allows sales of the organic product in California and signifies an important step in the company's commercialization strategy. TerraSanteTM focuses on soil microbiome health, nutrient efficiency, and plant yields, positioning it well in the organic agriculture market. MustGrow expects to expand its state-level registrations in the U.S., following successful registrations in California, Oregon, and Washington State. The product complements the company's existing biocontrol programs and targets key crops in California's agriculture market.
MustGrow Biologics Corp. has signed an exclusive distribution agreement with G.S. Long Co., Inc. for its TerraSanteTM biofertility product in Oregon and Washington State. TerraSanteTM is organic certified through the USDA National Organic Program, focusing on soil microbiome health, nutrient/water efficiencies, and plant yields. The agreement marks a significant milestone in MustGrow's commercialization strategy. G.S. Long Company is a well-established agricultural retailer with crop consultant capabilities, extending MustGrow's reach in the market. Sales in both states will be authorized under existing product registrations, with plans for further state-level registrations. Oregon and Washington present a strong market opportunity for organic produce, aligning with MustGrow's goals of sustainable agriculture practices.
FAQ
What is the current stock price of Mustgrow Biologics (MGROF)?
What is the market cap of Mustgrow Biologics (MGROF)?
